Analysis of CFTR expression in immune cell subsets of peripheral blood  by van Meegen, M.A. et al.
S56 6. Immunology
224 Analysis of CFTR expression in immune cell subsets of
peripheral blood
M.A. van Meegen1,2, S.W. Terheggen-Lagro1, H. Hoelen3, I. Braakman3,
P.J. Coffer2, C.K. van der Ent1, J.M. Beekman1,2. 1Pediatric Pulmonary Diseases,
UMC, Utrecht, Netherlands; 2Pediatric Immunology, UMC, Utrecht, Netherlands;
3Cellular Protein Chemistry, University of Utrecht, Utrecht, Netherlands
Background: Cystic ﬁbrosis lung disease is characterized by recurrent pulmonary
infections and a chronic inﬂammatory response. The underlying mechanisms
responsible for the inﬂammatory phenotype are still debated. CFTR dysfunction
in epithelial cells is generally accepted to play a role in disease. Several reports
also suggest CFTR mutations to contribute to chronic inﬂammatory conditions due
to an intrinsic defect of the immune system. Limited reports directly showed CFTR
expression in human PBMC using RT-PCR, western blot and indirectly by patch
clamp analysis. Here, we studied CFTR expression in multiple immune cell subsets
isolated from PBMC using a variety of techniques.
Methods: To examine CFTR expression in immune cell subsets, we separated
PBMC and granulocytes from peripheral blood of healthy donors using ﬁcoll
density centrifugation. CD4, CD8, CD19 and CD14 positive immune cells were
sorted from PBMC using ﬂow cytometry. CFTR expression was measured by RT-
PCR, western blot, metabolic labelling using 35-S labelled methionine and cysteine,
immune ﬂuorescence, and in vitro phosphorylation by PKA.
Results: Preliminary results show no detectable CFTR expression in any immune
cell subset.
Conclusions: Thus far, we cannot conﬁrm previous reports indicating CFTR
expression in PBMC.
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The innate immunity system has a primary role in the defence of the lung against
invasive pathogens. Nod-like receptors, an important family of receptors that forms
part of this defence system, have been an area of increasing interest lately. Activated
Nod-like receptors give rise to the formation of inﬂammasomes, protein complexes
that eventually lead to the secretion of pro-inﬂammatory cytokines. Changes in
Nod-like receptors have been associated with a number of diseases. In the current
study, we investigate the possible expression of Nod1 and Nod2 receptors on cystic
ﬁbrosis (CF) and non-CF bronchial epithelial cells.
Cystic ﬁbrosis (CFBE) and normal (16HBE) airway epithelial cells were cultured
under standard conditions in M199 medium at 37ºC. Reverse transcription of RNA
to cDNA was performed with TaqMan Reverse Transcription Reagents (Applied
Biosystems). Samples were analyzed by RT-PCR. The expression of Nod1 and Nod2
was analyzed by Western blot (using a goat-anti human antibody and a rabbit-anti
human antibody, respectively).
No difference in the expression of Nod1 could be observed with either method
between CF and non-CF cells. However, an approximately 30% lower mRNA and
protein expression for Nod2 were found in CF cells compared to non-CF airway
epithelial cells.
Defective Nod2 signalling may contribute to the pathogenesis of chronic lung
disease observed in CF patients.
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It has been recently reported that the absence of CFTR alters the bactericidal
activity of murine alveolar macrophages. In order to evaluate the role of CFTR
in human macrophages we have ﬁrst analyzed the CFTR expression in monocyte-
derived macrophages and subsequently we compared the bactericidal activity of
macrophages from CF and control subjects. Analysis of CFTR mRNA expression
by real time PCR in macrophages and parental monocytes isolated from twelve
healthy donors demonstrated an up-regulation of the mRNA levels in macrophages
from eight subjects.
Additionally we demonstrate the presence of the CFTR protein in human monocyte-
derived macrophages by confocal microscopy.
The bactericidal activity of in vitro differentiated macrophages from nine CF
subjects and seven healthy subjects was determined by the antibiotic protection
assay and the clinical isolate of Pseudomonas aeruginosa, PA27853. Viable bacteria
in cell lysates were determined at the end of gentamicin treatment (t0), and after 2
(t2) and 4 (t4) hours of incubation in antibiotic-free medium. Overall we observed
that CF and control macrophages did not differ in the ability to internalize and
kill P. aeruginosa although, when the data were analysed together, the mean value
of live bacteria 4 hr post infection, was higher in CF than in HD macrophages
(P = 0.032). Our results demonstrate the expression of CFTR in human monocyte-
derived macrophages and suggest that CFTR might be involved in bactericidal
activity.
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Cystic ﬁbrosis is characterized by a neutrophil-dominated inﬂammation. The reso-
lution of inﬂammation requires the phagocytosis of neutrophils by macrophages. In
cystic ﬁbrosis, neutrophils are massively recruited and persist in the airways. Neu-
trophils can secrete many proteinases such as proteinase 3 (PR3), which can have
deleterious effects on pulmonary tissue. PR3 is localised at the plasma membrane
under basal conditions, and PR3 membrane expression is increased during apopto-
sis. Moreover, apoptosis-induced PR3 membrane expression decreased macrophages
phagocytosis and thus interfering with the resolution of the inﬂammation.
The aim of the project is to characterize the membrane expression of PR3, which
acts as a neutrophil “don’t eat me signal”.
We tested whether membrane PR3 could mask an “eat-me signal” such as phos-
phatidylserine and calreticulin membrane expression in mast cell lines (RBL)
which were stably transfected with PR3. Apoptosis-induced phosphatidylserine
externalization and calreticulin membrane expression were not decreased in PR3-
expressing RBL. A mouse monoclonal anti-PR3 antibody reversed the inhibitory
effect on macrophage phagocytosis. Our results suggest that the PR3 inhibitory
activity toward macrophage phagocytosis does not imply modiﬁcation of known
“eat-me signal” on the apoptotic cell but might involve an interference at the level
of macrophage. Indeed, a better comprehension of the role of PR3 in cystic ﬁbrosis
will hopefully allow us to develop new anti-inﬂammatory treatments targeting
neutrophils.
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